Publication | Open Access

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Surgical OncologyBreast OncologyMedicineGynecologyAnastrozole Versus TamoxifenBreast CancerPharmacotherapyNsabp B-35OncologyRadiation OncologyGynecology OncologyEndocrine-related CancerPostmenopausal Women